Adcock Ingram Holdings Limited
Adcock Ingram Holdings Limited, together with its subsidiaries, engages in the manufacture, marketing, and distribution of healthcare products to private and public sectors in Southern Africa and India. It operates through four segments: Consumer, Over the Counter (OTC), Prescription, and Hospital Products and Services. The company provides various healthcare, personal care, and homecare products… Read more
Adcock Ingram Holdings Limited (AIHLF) - Net Assets
Latest net assets as of June 2025: $5.83 Billion USD
Based on the latest financial reports, Adcock Ingram Holdings Limited (AIHLF) has net assets worth $5.83 Billion USD as of June 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.74 Billion) and total liabilities ($2.90 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $5.83 Billion |
| % of Total Assets | 66.78% |
| Annual Growth Rate | 11.86% |
| 5-Year Change | 24.56% |
| 10-Year Change | 79.24% |
| Growth Volatility | 31.06 |
Adcock Ingram Holdings Limited - Net Assets Trend (2005–2025)
This chart illustrates how Adcock Ingram Holdings Limited's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Adcock Ingram Holdings Limited (2005–2025)
The table below shows the annual net assets of Adcock Ingram Holdings Limited from 2005 to 2025.
| Year | Net Assets | Change |
|---|---|---|
| 2025-06-30 | $5.83 Billion | +7.77% |
| 2024-06-30 | $5.41 Billion | +0.46% |
| 2023-06-30 | $5.39 Billion | +2.72% |
| 2022-06-30 | $5.25 Billion | +12.00% |
| 2021-06-30 | $4.68 Billion | +3.19% |
| 2020-06-30 | $4.54 Billion | +5.59% |
| 2019-06-30 | $4.30 Billion | +9.79% |
| 2018-06-30 | $3.91 Billion | +12.01% |
| 2017-06-30 | $3.50 Billion | +7.39% |
| 2016-06-30 | $3.25 Billion | +4.42% |
| 2015-06-30 | $3.12 Billion | +9.08% |
| 2014-06-30 | $2.86 Billion | -24.08% |
| 2013-06-30 | $3.76 Billion | +6.07% |
| 2012-06-30 | $3.55 Billion | +10.09% |
| 2011-06-30 | $3.22 Billion | +4.88% |
| 2010-06-30 | $3.07 Billion | +32.15% |
| 2009-06-30 | $2.33 Billion | +40.86% |
| 2008-06-30 | $1.65 Billion | +3368.80% |
| 2007-06-30 | $-50.51 Million | -113.13% |
| 2006-06-30 | $384.76 Million | -37.93% |
| 2005-06-30 | $619.84 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to Adcock Ingram Holdings Limited's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 883880200000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (June 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | $6.10 Billion | 104.57% |
| Common Stock | $14.68 Million | 0.25% |
| Total Equity | $5.83 Billion | 100.00% |
Adcock Ingram Holdings Limited Competitors by Market Cap
The table below lists competitors of Adcock Ingram Holdings Limited ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Aurelius Technologies Bhd
KLSE:5302
|
$85.61 Million |
|
Dongwon System
KO:014820
|
$85.64 Million |
|
BGF Retail Co Ltd
KO:027410
|
$85.64 Million |
|
Kamada
NASDAQ:KMDA
|
$85.65 Million |
|
Arise AB (publ)
F:A4W
|
$85.56 Million |
|
Alkim Alkali Kimya AS
IS:ALKIM
|
$85.56 Million |
|
ECIT AS NK 1
F:3CZ
|
$85.56 Million |
|
Arlandastad Group AB
ST:AGROUP
|
$85.55 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Adcock Ingram Holdings Limited's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 5,412,820,000 to 5,833,486,000, a change of 420,666,000 (7.8%).
- Net income of 858,514,000 contributed positively to equity growth.
- Other comprehensive income decreased equity by 239,737,000.
- Other factors decreased equity by 107,350,000.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $858.51 Million | +14.72% |
| Other Comprehensive Income | $-239.74 Million | -4.11% |
| Other Changes | $-107.35 Million | -1.84% |
| Total Change | $- | 7.77% |
Book Value vs Market Value Analysis
This analysis compares Adcock Ingram Holdings Limited's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.06x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2005-06-30 | $-15.36 | $2.45 | x |
| 2006-06-30 | $-11.00 | $2.45 | x |
| 2007-06-30 | $-0.41 | $2.45 | x |
| 2008-06-30 | $9.38 | $2.45 | x |
| 2009-06-30 | $13.24 | $2.45 | x |
| 2010-06-30 | $16.74 | $2.45 | x |
| 2011-06-30 | $18.04 | $2.45 | x |
| 2012-06-30 | $20.24 | $2.45 | x |
| 2013-06-30 | $21.55 | $2.45 | x |
| 2014-06-30 | $16.24 | $2.45 | x |
| 2015-06-30 | $17.87 | $2.45 | x |
| 2016-06-30 | $19.39 | $2.45 | x |
| 2017-06-30 | $20.97 | $2.45 | x |
| 2018-06-30 | $23.53 | $2.45 | x |
| 2019-06-30 | $25.84 | $2.45 | x |
| 2020-06-30 | $26.69 | $2.45 | x |
| 2021-06-30 | $28.21 | $2.45 | x |
| 2022-06-30 | $31.83 | $2.45 | x |
| 2023-06-30 | $32.90 | $2.45 | x |
| 2024-06-30 | $35.00 | $2.45 | x |
| 2025-06-30 | $38.81 | $2.45 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Adcock Ingram Holdings Limited utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.72%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 8.80%
- • Asset Turnover: 1.12x
- • Equity Multiplier: 1.50x
- Recent ROE (14.72%) is above the historical average (13.06%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2005 | 0.00% | 23.18% | 1.58x | 0.00x | $1.04 Billion |
| 2006 | 0.00% | 20.60% | 1.20x | 0.00x | $982.79 Million |
| 2007 | 0.00% | 9.69% | 2.29x | 0.00x | $567.41 Million |
| 2008 | 40.11% | 18.86% | 1.28x | 1.67x | $490.25 Million |
| 2009 | 34.01% | 19.53% | 1.18x | 1.47x | $552.33 Million |
| 2010 | 21.66% | 15.29% | 0.87x | 1.63x | $339.99 Million |
| 2011 | 24.44% | 16.93% | 0.85x | 1.70x | $445.63 Million |
| 2012 | 20.61% | 15.34% | 0.89x | 1.50x | $363.34 Million |
| 2013 | 16.17% | 11.32% | 0.77x | 1.86x | $224.25 Million |
| 2014 | -33.38% | -18.47% | 0.92x | 1.97x | $-1.19 Billion |
| 2015 | 6.56% | 3.84% | 0.95x | 1.81x | $-103.81 Million |
| 2016 | 5.23% | 3.04% | 0.99x | 1.73x | $-154.06 Million |
| 2017 | 15.87% | 9.32% | 1.07x | 1.60x | $204.79 Million |
| 2018 | 16.31% | 9.99% | 1.02x | 1.60x | $246.69 Million |
| 2019 | 16.02% | 9.72% | 1.13x | 1.46x | $258.44 Million |
| 2020 | 14.91% | 9.21% | 1.02x | 1.58x | $222.79 Million |
| 2021 | 14.04% | 8.45% | 1.10x | 1.50x | $189.23 Million |
| 2022 | 15.26% | 9.19% | 1.10x | 1.50x | $275.86 Million |
| 2023 | 16.67% | 9.84% | 1.11x | 1.53x | $359.62 Million |
| 2024 | 15.04% | 8.44% | 1.15x | 1.54x | $272.73 Million |
| 2025 | 14.72% | 8.80% | 1.12x | 1.50x | $275.17 Million |
Industry Comparison
This section compares Adcock Ingram Holdings Limited's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $267,907,348
- Average return on equity (ROE) among peers: -502.70%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Adcock Ingram Holdings Limited (AIHLF) | $5.83 Billion | 0.00% | 0.50x | $85.61 Million |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |